First Trust Switzerland AlphaDEX Fund Stock Forecast, Price & News

First Trust Switzerland AlphaDEX Fund's stock was trading at $45.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FSZ shares have increased by 26.1% and is now trading at $57.14.
View which stocks have been most impacted by COVID-19.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for First Trust Switzerland AlphaDEX Fund in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for First Trust Switzerland AlphaDEX Fund or view MarketBeat's top 5 stock picks.

Wall Street analysts have given First Trust Switzerland AlphaDEX Fund a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but First Trust Switzerland AlphaDEX Fund wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

First Trust Switzerland AlphaDEX Fund (NASDAQ:FSZ) released its earnings results on Thursday, March, 19th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.27 by $0.07.
View First Trust Switzerland AlphaDEX Fund's earnings history.

First Trust Switzerland AlphaDEX Fund declared a quarterly dividend on Wednesday, June 24th. Investors of record on Friday, June 26th will be paid a dividend of $0.768 per share on Tuesday, June 30th. This represents a $3.07 dividend on an annualized basis and a yield of 5.38%. The ex-dividend date of this dividend is Thursday, June 25th.
View First Trust Switzerland AlphaDEX Fund's dividend history.

1 equities research analysts have issued 12 month price targets for First Trust Switzerland AlphaDEX Fund's stock. Their forecasts range from $10.00 to $10.00. On average, they anticipate First Trust Switzerland AlphaDEX Fund's stock price to reach $10.00 in the next twelve months. This suggests that the stock has a possible downside of 82.5%.
View analysts' price targets for First Trust Switzerland AlphaDEX Fund.

First Trust Switzerland AlphaDEX Fund saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 1,800 shares, a decrease of 81.6% from the October 31st total of 9,800 shares. Based on an average trading volume of 4,700 shares, the days-to-cover ratio is presently 0.4 days.
View First Trust Switzerland AlphaDEX Fund's Short Interest.

First Trust Switzerland AlphaDEX Fund trades on the NASDAQ under the ticker symbol "FSZ."

First Trust Switzerland AlphaDEX Fund's stock is owned by a number of retail and institutional investors. Top institutional shareholders include First Trust Advisors LP (59.20%), Morgan Stanley (7.14%), Wells Fargo & Company MN (3.78%), Raymond James & Associates (3.03%), LPL Financial LLC (0.47%) and Vontobel Swiss Wealth Advisors AG (0.30%).

FSZ stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Morgan Stanley, and LPL Financial LLC.

FSZ stock was bought by a variety of institutional investors in the last quarter, including Raymond James & Associates, Wells Fargo & Company MN, Vontobel Swiss Wealth Advisors AG, and Catalyst Private Wealth LLC.

Shares of FSZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FSZ stock can currently be purchased for approximately $57.14.

First Trust Switzerland AlphaDEX Fund has a market capitalization of $77.14 million.